E. A. Oral Et Al. , "Inhibition of IKK 3 and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes," CELL METABOLISM , vol.26, no.1, pp.157-177, 2017
Oral, E. A. Et Al. 2017. Inhibition of IKK 3 and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. CELL METABOLISM , vol.26, no.1 , 157-177.
Oral, E. A., Reilly, S. M., Gomez, A. V., Meral, R., Butz, L., Ajluni, N., ... Chenevert, T. L.(2017). Inhibition of IKK 3 and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. CELL METABOLISM , vol.26, no.1, 157-177.
Oral, Elif Et Al. "Inhibition of IKK 3 and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes," CELL METABOLISM , vol.26, no.1, 157-177, 2017
Oral, Elif A. Et Al. "Inhibition of IKK 3 and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes." CELL METABOLISM , vol.26, no.1, pp.157-177, 2017
Oral, E. A. Et Al. (2017) . "Inhibition of IKK 3 and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes." CELL METABOLISM , vol.26, no.1, pp.157-177.
@article{article, author={Elif A. Oral Et Al. }, title={Inhibition of IKK 3 and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes}, journal={CELL METABOLISM}, year=2017, pages={157-177} }